Assessment of major gaps

Dec 19, 2019

Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.

Recent News

Neuroendocrine Cancer Surgical Specialty Lead (SSL) Appointed

Neuroendocrine Cancer Surgical Specialty Lead (SSL) Appointed

- As part of our ‘Advancing Neuroendocrine Cancer Research’ campaign, we are delighted to announce the appointment of a neuroendocrine cancer Surgical Specialty Lead (SSL). This is the first time such a role has been established specifically for neuroendocrine cancer,...

read more
NETTER-2 Study Results: Looking Beyond The headlines.

NETTER-2 Study Results: Looking Beyond The headlines.

The latest breakthrough in neuroendocrine cancer treatment comes from the NETTER-2 trial, where Lutetium (177Lu) oxodotreotide, a radio-labeled somatostatin analog, has shown remarkable success in treating high-grade advanced gastroenteropancreatic neuroendocrine...

read more
Unwind Your Mind: Join Our 8-Week Mindfulness Programme

Unwind Your Mind: Join Our 8-Week Mindfulness Programme

- Mindfulness for Managing Pain, Anxiety and Fatigue In March 2023, our counselling and psychotherapy partners at RareMinds ran an Online (Zoom) taster session on ‘Mindfulness for Pain and Fatigue’ for our Neuroendocrine Cancer community. Following on from the...

read more